Morgan Stanley’s Core Laboratories CLB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $7.5M | Sell |
446,782
-38,256
| -8% | -$684K | ﹤0.01% | 3813 |
|
|
2025
Q4 | $7.78M | Sell |
485,038
-19,156
| -4% | -$285K | ﹤0.01% | 3834 |
|
|
2025
Q3 | $6.23M | Buy |
504,194
+22,649
| +5% | +$266K | ﹤0.01% | 3969 |
|
|
2025
Q2 | $5.55M | Sell |
481,545
-108,034
| -18% | -$1.28M | ﹤0.01% | 3981 |
|
|
2025
Q1 | $8.84M | Sell |
589,579
-305,193
| -34% | -$5.11M | ﹤0.01% | 3454 |
|
|
2024
Q4 | $15.5M | Sell |
894,772
-113,282
| -11% | -$2.19M | ﹤0.01% | 3006 |
|
|
2024
Q3 | $18.7M | Sell |
1,008,054
-67,048
| -6% | -$1.35M | ﹤0.01% | 2868 |
|
|
2024
Q2 | $21.8M | Buy |
1,075,102
+31,421
| +3% | +$556K | ﹤0.01% | 2569 |
|
|
2024
Q1 | $17.8M | Sell |
1,043,681
-411,351
| -28% | -$6.47M | ﹤0.01% | 2824 |
|
|
2023
Q4 | $25.7M | Buy |
1,455,032
+767,748
| +112% | +$15.5M | ﹤0.01% | 3117 |
|
|
2023
Q3 | $16.5M | Buy |
687,284
+160,139
| +30% | +$3.93M | ﹤0.01% | 2654 |
|
|
2023
Q2 | $12.3M | Buy |
527,145
+96,718
| +22% | +$2.19M | ﹤0.01% | 2971 |
|
|
2023
Q1 | $9.49M | Buy |
430,427
+27,587
| +7% | +$646K | ﹤0.01% | 3197 |
|
|
2022
Q4 | $8.17M | Buy |
402,840
+43,154
| +12% | +$836K | ﹤0.01% | 3271 |
|
|
2022
Q3 | $4.85M | Buy |
359,686
+2,116
| +0.6% | +$35.7K | ﹤0.01% | 3726 |
|
|
2022
Q2 | $7.08M | Buy |
357,570
+72,872
| +26% | +$1.94M | ﹤0.01% | 3434 |
|
|
2022
Q1 | $9.01M | Sell |
284,698
-21,167
| -7% | -$593K | ﹤0.01% | 3025 |
|
|
2021
Q4 | $6.83M | Sell |
305,865
-16,871
| -5% | -$440K | ﹤0.01% | 3389 |
|
|
2021
Q3 | $8.96M | Sell |
322,736
-297,982
| -48% | -$9.07M | ﹤0.01% | 3030 |
|
|
2021
Q2 | $24.2M | Buy |
620,718
+472,415
| +319% | +$16.9M | ﹤0.01% | 1955 |
|
|
2021
Q1 | $4.27M | Sell |
148,303
-2,310
| -2% | -$78.9K | ﹤0.01% | 3574 |
|
|
2020
Q4 | $3.99M | Buy |
150,613
+16,498
| +12% | +$337K | ﹤0.01% | 3500 |
|
|
2020
Q3 | $2.05M | Buy |
134,115
+3,885
| +3% | +$81.5K | ﹤0.01% | 3639 |
|
|
2020
Q2 | $2.65M | Sell |
130,230
-746,196
| -85% | -$13.4M | ﹤0.01% | 3325 |
|
|
2020
Q1 | $9.06M | Buy |
876,426
+507,141
| +137% | +$14.2M | ﹤0.01% | 1876 |
|
|
2019
Q4 | $13.9M | Buy |
369,285
+89,116
| +32% | +$4M | ﹤0.01% | 2039 |
|
|
2019
Q3 | $13.1M | Buy |
280,169
+68,262
| +32% | +$3.17M | ﹤0.01% | 1862 |
|
|
2019
Q2 | $11.1M | Buy |
211,907
+25,130
| +13% | +$1.47M | ﹤0.01% | 2040 |
|
|
2019
Q1 | $12.9M | Buy |
186,777
+75,395
| +68% | +$5.05M | ﹤0.01% | 1791 |
|
|
2018
Q4 | $6.65M | Sell |
111,382
-63,371
| -36% | -$5.47M | ﹤0.01% | 2552 |
|
|
2018
Q3 | $20.2M | Sell |
174,753
-14,211
| -8% | -$1.6M | 0.01% | 1671 |
|
|
2018
Q2 | $23.8M | Sell |
188,964
-32,114
| -15% | -$3.91M | 0.01% | 1475 |
|
|
2018
Q1 | $23.9M | Sell |
221,078
-17,879
| -7% | -$1.98M | 0.01% | 1507 |
|
|
2017
Q4 | $26.2M | Buy |
238,957
+11,667
| +5% | +$1.16M | 0.01% | 1436 |
|
|
2017
Q3 | $22.4M | Buy |
227,290
+75,567
| +50% | +$7.33M | 0.01% | 1476 |
|
|
2017
Q2 | $15.4M | Sell |
151,723
-15,742
| -9% | -$1.7M | ﹤0.01% | 1759 |
|
|
2017
Q1 | $19.3M | Buy |
167,465
+24,929
| +17% | +$2.9M | 0.01% | 1604 |
|
|
2016
Q4 | $17.1M | Sell |
142,536
-45,063
| -24% | -$4.99M | 0.01% | 1680 |
|
|
2016
Q3 | $21.1M | Sell |
187,599
-22,943
| -11% | -$2.64M | 0.01% | 1403 |
|
|
2016
Q2 | $26.1M | Sell |
210,542
-217,488
| -51% | -$26.3M | 0.01% | 1221 |
|
|
2016
Q1 | $48.1M | Sell |
428,030
-242,401
| -36% | -$25.2M | 0.02% | 773 |
|
|
2015
Q4 | $72.9M | Sell |
670,431
-185,988
| -22% | -$21.3M | 0.03% | 614 |
|
|
2015
Q3 | $85.5M | Sell |
856,419
-20,157
| -2% | -$2.19M | 0.03% | 531 |
|
|
2015
Q2 | $100M | Sell |
876,576
-26,088
| -3% | -$3.16M | 0.03% | 511 |
|
|
2015
Q1 | $94.3M | Sell |
902,664
-42,847
| -5% | -$4.56M | 0.03% | 524 |
|
|
2014
Q4 | $114M | Sell |
945,511
-133,935
| -12% | -$17.6M | 0.04% | 461 |
|
|
2014
Q3 | $158M | Sell |
1,079,446
-217,126
| -17% | -$33.5M | 0.06% | 350 |
|
|
2014
Q2 | $217M | Buy |
1,296,572
+93,365
| +8% | +$16.6M | 0.08% | 265 |
|
|
2014
Q1 | $239M | Buy |
1,203,207
+198,824
| +20% | +$37.5M | 0.1% | 235 |
|
|
2013
Q4 | $192M | Buy |
1,004,383
+158,206
| +19% | +$29.4M | 0.08% | 277 |
|
|
2013
Q3 | $143M | Buy |
846,177
+131,029
| +18% | +$20.3M | 0.07% | 333 |
|
|
2013
Q2 | $108M | Buy |
+715,148
| New | +$101M | 0.05% | 379 |
|
Other funds holding CLB
AI
DGI
CAMG
VCM
VPM
Morgan Stanley's CLB Position: Q1 2026 in Review
Morgan Stanley reduced its Core Laboratories (CLB) stake by 7.9% in Q1 2026, selling an estimated $684K and leaving 446,782 shares worth $7.5M. The position accounts for ﹤0.01% of the portfolio, ranked #3813.
Morgan Stanley first reported a position in CLB in Q2 2013 and has held it in 52 quarters since. The position peaked at $239M in Q1 2014. 190 funds tracked by Wall St. Rank hold CLB as of Q1 2026.
- Morgan Stanley held 446,782 shares of Core Laboratories worth $7.5M as of Q1 2026.
- Morgan Stanley sold 38,256 Core Laboratories shares in Q1 2026, an estimated $684K.
- Core Laboratories made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #3813 holding.
- Morgan Stanley first reported a position in Core Laboratories in Q2 2013 and has held it in 52 quarters since.
- Morgan Stanley's Core Laboratories position peaked at $239M in Q1 2014.
- 190 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2026.
Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.